Exhibit 107
Calculation Of Filing Fee Tables
Form S-8
(Form Type)
Axsome Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type |
| Security Class |
| Fee |
| Amount |
|
| Proposed |
|
| Maximum |
|
| Fee Rate |
|
| Amount of |
| |||||
Equity |
| Common stock, $0.0001 par value per share |
| Rule 457(c) and Rule 457(h) |
|
| 1,894,054 |
|
| $ | 84.26 |
|
| $ | 159,592,990 |
|
| $ | 0.0001476 |
|
| $ | 23,556 |
|
Total Offering Amounts |
|
| $ | 23,556 |
| |||||||||||||||||||
Total Fee Offsets |
|
|
| — |
| |||||||||||||||||||
Net Fee Due |
|
| $ | 23,556 |
| |||||||||||||||||||
|
|
|
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement (the "Registration Statement") shall also cover any additional shares of the Registrant's common stock, $0.0001 par value per share (the "Common Stock") that becomes issuable under the Registrant's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the "Plan") by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that increases the number of the Registrant's outstanding shares of Common Stock. |
| (2) | This Registration Statement covers 1,894,054 shares of the Registrant's Common Stock, which are issuable pursuant to the Plan. |
| (3) | Estimated in accordance with Rule 457(c) and (h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $84.26, the average of the high and low prices of the Registrant's common stock as reported on The Nasdaq Global Market on August 2, 2024. |
